Isturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes?

Watchdoq April 22, 2025
(MedPage Today) -- The FDA expanded the approval of osilodrostat (Isturisa) to include treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or was not curative, said maker Recordati.
The...

Read Full Article